Intrathecal clonidine for controlling spastic hypertonia
Rémy-Néris, O.; Denys, P.; Bussel, B.
Physical Medicine and Rehabilitation Clinics of North America 12(4): 939
2001
ISSN/ISBN: 1047-9651 PMID: 11723871 Document Number: 539216
Intrathecal clonidine is a powerful antispastic drug. Its mechanism of action is more selective than baclofen. The acute effects are reviewed. An assessment of side effects of clonidine during chronic infusion is needed.
Document emailed within 1 workday
Related Documents
Eisenach, J.C.; Gebhart, G.F. 1995: Intrathecal amitriptyline. Antinociceptive interactions with intravenous morphine and intrathecal clonidine, neostigmine, and carbamylcholine in rats Anesthesiology 83(5): 1036-1045Meythaler, J.M. 2001: Spastic hypertonia. Appendix Physical Medicine and Rehabilitation Clinics of North America 12(4): 953
Casale, R.; Glynn, C.J.; Buonocore, M. 1995: Reduction of spastic hypertonia in patients with spinal cord injury: a double-blind comparison of intravenous orphenadrine citrate and placebo Archives of Physical Medicine and Rehabilitation 76(7): 660-665
Rubin, L.; Koeberlé, P.; Bachour, K.; Bettinger, G.; Barale, F. 1995: Hemodynamic effect of intrathecal clonidine Cahiers d'Anesthesiologie 43(3): 307-312
Calabro, R.S.; Bramanti, P. 2013: Intrathecal clonidine administration and erectile dysfunction: what is the link? Pain Physician 16(2): E119-E120
Nakajima, T.; Akagawa, H.; Ochiai, T.; Hayashi, M.; Goto, S.; Taira, T.; Okada, Y. 2009: Intrathecal baclofen therapy for spastic paraparesis due to aortic dissecting aneurysm; recent progress in treatment strategy Kyobu Geka. Japanese Journal of Thoracic Surgery 62(12): 1039-1042
González-Elipe, J.; Vilanova, A.; Rapado, A.; Fernández-Criado, M.; Perianes, J. 1970: Strümpell-Lorrain's spastic paraplegia (primary lateral sclerosis, familial spastic paralysis, etc.) Revista Clinica Espanola 119(3): 233-240
Van Eys, J.; Chen, T.; Moore, T.; Cheek, W.; Sexauer, C.; Starling, K. 1981: Adjuvant chemotherapy for medulloblastoma and ependymoma using iv vincristine, intrathecal methotrexate, and intrathecal hydrocortisone: a Southwest Oncology Group Study Cancer Treatment Reports 65(7-8): 681-684
Roth, R.H.; Elsworth, J.D.; Redmond, D.E. 1982: Clonidine suppression of noradrenergic hyperactivity during morphine withdrawal by clonidine: biochemical studies in rodents and primates Journal of Clinical Psychiatry 43(6 Part 2): 42-46
Arndts, D.; Doevendans, J.; Arendt, G.; Rippen, G. 1981: Pharmacokinetics of clonidine and chlorthalidone following subacute administration of a fixed combination compared with a sustained release formulation of clonidine alone Arzneimittel-Forschung 31(11): 1954-1957
D'Amelio, G.; Dalla Volta, S.; De Longhi, B.; Razzolini, R. 1974: Antihypertensive effects of clonidine and of the clonidine-chlorthalidone combination Minerva Medica 65(41): 2342-2349
De Ley, G.; De Moor, A. 1975: Bovine spastic paralysis: cerebrospinal fluid concentrations of homovanillic acid and 5-hydroxyindoleacetic acid in normal and spastic calves American Journal of Veterinary Research 36(2): 227-228
Kanda, T.; Yuge, M.; Yamori, Y.; Fukase, H.; Yoshioka, H.; Morikawa, Y. 1984: A case of spastic diplegia treated by the Vojta procedure in early infancy with a remarkable effect. A comparison with 66 spastic diplegia children No to Hattatsu 16(4): 290-300
Moeller, J. 1970: Epidemiology of essential Hypertonia Therapie der Gegenwart 109(11): 1594 Passim
Lobera, E.; Campistol, J.; García-García, J.J.; Colomer, J.; Riverola, A. 1997: Congenital hyperekplexia as a cause of neonatal hypertonia Revista de Neurologia 25(137): 86-88
Wagner, S.L.; Orwick, D.L. 1994: Chronic organophosphate exposure associated with transient hypertonia in an infant Pediatrics 94(1): 94-97
De Rohan Chabot, P.; Elkharrat, D.; Conso, F.; Bismuth, C.; Goulon, M. 1982: Neuroleptic malignant syndrome. Beneficial effects of dantrolene on hyperthermia and hypertonia La Nouvelle Presse Medicale 11(14): 1067-1069
Hashimoto, N.; Kagitani-Shimono, K.; Tominaga, K.; Kitai, Y.; Ikeda, T.; Okinaga, T.; Taniike, M.; Ozone, K. 2012: Effects of botulinum toxin therapy for respiratory distress in patients with cervical hypertonia No to Hattatsu 44(1): 13-18
Chiriboga, C.A.; Vibbert, M.; Malouf, R.; Suarez, M.S.; Abrams, E.J.; Heagarty, M.C.; Brust, J.C.; Hauser, W.A. 1995: Neurological correlates of fetal cocaine exposure: transient hypertonia of infancy and early childhood Pediatrics 96(6): 1070-1077
Ivanichev, G.A. 1983: Functional status of cervical segments of the spinal cord in patients with local muscle hypertonia Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 83(5): 646-650